Peptide receptor radionuclide therapy for aggressive pituitary tumors: a monocentric experience

Management of NFAs: medical treatment

(2018) Naomi Even-Zohar et al.   Pituitary

Temozolomide treatment can improve overall survival in aggressive pituitary tumors and pituitary carcinomas

(2017) Hélène Lasolle et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Aggressive Pituitary Adenomas: The Dark Side of the Moon

(2017) Stefano M. Priola et al.   World Neurosurgery

Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline

(2016) Maria Fleseriu et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Growth hormone–secreting macroadenoma of the pituitary gland successfully treated with the radiolabeled somatostatin analog 90Y-DOTATATE: case report

(2016) Joanna Waligórska-Stachura et al.   JOURNAL OF NEUROSURGERY

Long-Term Outcome and MGMT as a Predictive Marker in 24 Patients With Atypical Pituitary Adenomas and Pituitary Carcinomas Given Treatment With Temozolomide

(2015) Daniel Bengtsson et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Temozolomide therapy in patients with aggressive pituitary adenomas or carcinomas

(2015) Marco Losa et al.   JOURNAL OF NEURO-ONCOLOGY

Aggressive Pituitary Tumors

(2015) Eleftherios Chatzellis et al.   NEUROENDOCRINOLOGY

Somatostatin receptor ligands and resistance to treatment in pituitary adenomas

(2014) Daniel Cuevas-Ramos et al.   JOURNAL OF MOLECULAR ENDOCRINOLOGY

The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours

(2013) John J. Zaknun et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Peptide receptor radionuclide therapy in a patient with disabling non-functioning pituitary adenoma

(2013) Jan Komor et al.   Pituitary

Peptide receptor radionuclide therapy for aggressive atypical pituitary adenoma/carcinoma: variable clinical response in preliminary evaluation

(2013) Jillian Maclean et al.   Pituitary

ACTH-secreting Crooke cell carcinoma of the pituitary

(2012) Gábor L. Kovács et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

First demonstration of the effectiveness of peptide receptor radionuclide therapy (PRRT) with 111In-DTPA-octreotide in a giant PRL-secreting pituitary adenoma resistant to conventional treatment

(2012) S. Baldari et al.   Pituitary

Resistance to Somatostatin Analogs in Acromegaly

(2011) Annamaria Colao et al.   ENDOCRINE REVIEWS

Temozolomide-Induced Shrinkage of a Pituitary Carcinoma Causing Cushing's Disease — Report of a Case and Literature Review

(2011) Lorenzo Curtò et al.   TheScientificWorldJOURNAL

Treatment With the Radiolabeled Somatostatin Analog [177Lu-DOTA0,Tyr3]Octreotate: Toxicity, Efficacy, and Survival

(2008) Dik J. Kwekkeboom et al.   JOURNAL OF CLINICAL ONCOLOGY